GRANULES INDIA LIMITED
	Regd Office : 2nd Floor, 3rd Block, My Home Hub
	Madhapur, Hyderabad 500 081
	UNAUDITED FINANCIAL RESULTS - STANDALONE
	FOR THE QUARTER ENDED 30th SEPTEMBER, 2011
							(Rs. Lakhs)
	Sl  No.	Particulars	3 Months ended    30th Sept, 2011	Corresponding 3 months ended in the previous year 30th Sept, 2010	Year to date figures for current half year ended            30th Sept, 2011	Year to date figures for previous half  year ended 30th Sept, 2010	Previous accounting year ended 31st March, 2011
			Unaudited	Unaudited	Unaudited	Unaudited	Audited
	1	Net sales / Income from Operations	14,008.27	10,020.83	24,169.35	19,072.24	40,567.70
	2	Expenditure
		a) (Increase)/decrease in finished goods
		and work in progress	907.29	99.45	(417.05)	(317.75)	(142.84)
		b) Consumption of Raw Materials	8,344.75	6,196.84	15,884.57	12,180.91	25,270.02
		c) Employee cost	885.89	754.50	1,824.29	1,380.64	2,745.46
		d) Depreciation	434.97	387.61	863.66	772.36	1,588.13
		e) Manufacturing Expenses	706.49	593.37	1,378.06	1,260.53	2,582.08
		f) Administrative Expenses	323.18	321.18	740.38	612.68	1,297.22
		g) Selling & Distribution Expenses	1,167.29	786.40	1,920.26	1,449.51	3,266.78
		h) R &  D Expenses	45.31	110.88	65.95	148.41	138.40
		i) Other expenditure	14.51	13.92	29.01	27.84	55.69
		Total	12,829.68	9,264.15	22,289.15	17,515.13	36,800.94
	3	Profit from Operations before Other Income, Interest & Exceptional Items (1-2)	1,178.60	756.68	1,880.21	1,557.11	3,766.76
	4	Other Income	(24.55)	(13.86)	(36.82)	(20.47)	(71.17)
	5	Profit before Interest and Exceptional Items	1,203.15	770.55	1,917.03	1,577.58	3,837.93
	6	Interest and Finance charges	337.38	279.61	621.43	567.06	1,136.20
	7	Profit after Interest but before exceptional items	865.77	490.93	1,295.59	1,010.52	2,701.73
	8	Foreign Exchange Fluctuations (gain)/loss	363.55	(194.17)	358.18	16.87	(38.10)
	9	Profit before taxation	502.22	685.10	937.42	993.65	2,739.83
	10	Tax expense
		- Current Tax Expense	113.35	68.83	207.23	130.33	285.49
		- Deferred Tax Expense	40.21	84.38	73.65	141.26	282.51
	11	Net Profit for the period	348.66	531.89	656.54	722.06	2,171.83
	12	Paid-up share capital	2,006.17	2,005.72	2,006.17	2,005.72	2,005.72
		(Face Value of Rs.10/- each)
	13	Reserves excluding Revaluation Reserve	20,691.22	18,933.00	20,691.22	18,933.00	20,033.10
	14	Basic Earnings per share (Rs.)*	1.74	2.65	3.27	3.60	10.83
	15	Diluted Earning per share (Rs) *	1.73	2.64	3.26	3.58	10.78
	16	Public Shareholding
		- No. of shares	11,899,764	12,548,775	11,899,764	12,548,775	12,152,162
		- Percentage of shareholding	59.32%	62.57%	59.32%	62.57%	60.59%
	17	Promoters and promoter group
		Shareholding
		a) Pledged/Encumbered
		Number of shares	5,134,875	400,000	5,134,875	400,000	1,759,375
		Percentage of shares to promoter group	62.91%	5.77%	62.91%	5.77%	22.26%
		Percentage of shares to total capital	25.60%	1.99%	25.60%	1.99%	8.77%
		b) Non-encumbered
		Number of shares	3,027,015	6,535,339	3,027,015	6,535,339	6,145,617
		Percentage of shares to promoter group	37.09%	94.23%	37.09%	94.23%	77.74%
		Percentage of shares to total capital	15.09%	32.58%	15.09%	32.58%	30.64%
	* Not Annualised  for Quarter ending
	1) The above  results were reviewed by the Audit Committee and approved by the Board at its meeting  held on 17th October, 2011
	2) The company has received 8 complaints from investors during the quarter 1st July, 2011 to 30th September, 2011 and all were resolved.
	No complaints were pending from previous quarter.
	3) The Company operates only in the segment of Pharmaceuticals.
	4) Figures are regrouped wherever necessary.
						for and on behalf of the Board
	Place  : Hyderabad					Dr.C.Nageswara Rao
	Date  : October 17, 2011					Chairman